Algalithe
Algalithe, licence 80128504: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Rebuild
- Licence holder
- B Ingredients Inc.
- NPN or DIN-HM
- 80128504
- Status
- Active licence
- Licence date
- 12 December 2023
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Phymatolithon calcareum Source : Phymatolithon calcareum - entier Potency : 32.0 % Calcium | 500.0 mg | Not calculated |
| Phymatolithon calcareum Source : Phymatolithon calcareum - entier Potency : 2.0 % Magnesium | Not specified | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 ans | 1.0 Capsule | minimum: 1.0 Tous les jours ; maximum: 5.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the development and maintenance of bones/(and) teeth (especially young adults). Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). As part of a healthy diet (when taken with Vitamin D) may help prevent bone loss/osteoporosis. Source of/Provides (an) electrolyte(s) (for the maintenance of good health). Helps to maintain/support normal muscle function. Helps maintain/support bone health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80128504
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.